Hazlett, Burt & Watson, Inc. Abb Vie Inc. Transaction History
Hazlett, Burt & Watson, Inc.
- $222 Million
- Q1 2025
A detailed history of Hazlett, Burt & Watson, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 9,477 shares of ABBV stock, worth $1.77 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
9,477
Previous 9,277
2.16%
Holding current value
$1.77 Million
Previous $1.65 Million
20.23%
% of portfolio
0.89%
Previous 0.73%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,264Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.6 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.3 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.71 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $331B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...